Emergence of Drug Resistance Mutations in Human Immunodeficiency Virus Type 2Infected Subjects Undergoing Antiretroviral Therapy (original) (raw)
… of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations …
Florian Liegeois
Journal of clinical …, 2000
View PDFchevron_right
Resistance Mutations in Protease and Reverse Transcriptase Genes of Human Immunodeficiency Virus Type 1 Isolates from Patients with Combination Antiretroviral Therapy Failure
Rob Ramey
The Journal of Infectious Diseases, 1998
View PDFchevron_right
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients
Laura Monno, F. Mazzotta
Journal of Medical Virology, 2004
View PDFchevron_right
Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals
Maria Eugenia QUIROS ROLDAN
Clinical Microbiology and Infection, 2004
View PDFchevron_right
The genetic basis of HIV-1 resistance to reverse transcriptase and protease inhibitors
Robert Shafer
2000
View PDFchevron_right
Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection
Tomozumi Imamichi
View PDFchevron_right
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients
Souleymane Mboup
Journal of clinical microbiology, 2000
View PDFchevron_right
Antiretroviral Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Protease from Paired Cerebrospinal Fluid and Plasma Samples
Carla Silva
The Journal of Infectious Diseases, 2000
View PDFchevron_right
Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors
Antonella Monforte
Antimicrobial Agents and Chemotherapy, 2005
View PDFchevron_right
Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern France
Jacques Moreau
Journal of Clinical Microbiology, 2004
View PDFchevron_right
HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
Robert Shafer
Antimicrobial Agents and Chemotherapy, 2010
View PDFchevron_right
Frequency of Protease and Reverse Transcriptase Drug Resistance Mutations in Naïve HIV-Infected Patients
Hugo Barrera-saldaña
Archives of Medical Research, 2006
View PDFchevron_right
Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease
Malcolm McCrae
Journal of Medical Virology, 2005
View PDFchevron_right
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor
Tomas Pumarola
AIDS, 2005
View PDFchevron_right
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
guy francis nzengui nzengui
BMC infectious diseases, 2024
View PDFchevron_right
Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
Marta Pingarilho
Annals of Medicine, 2021
View PDFchevron_right
Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India
mohd azam
Virus Genes, 2013
View PDFchevron_right
Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
Adetayo Obasa
Frontiers in Microbiology
View PDFchevron_right
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1
Danuta Pieniazek
AIDS, 2004
View PDFchevron_right
Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G
Anne-mieke Vandamme
Infection, Genetics and Evolution, 2010
View PDFchevron_right
Highly Active Antiretroviral Therapy Failure and Protease and Reverse Transcriptase Human Immunodeficiency Virus Type 1 Gene Mutations
Laura Monno
The Journal of Infectious Diseases, 1999
View PDFchevron_right
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments
Andrew Zolopa
Journal of Virology, 2003
View PDFchevron_right
Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India
Abida Malik
The Journal of Infection in Developing Countries, 2014
View PDFchevron_right
Drug Resistance Pathways and Impact of Protease Mutation L10I/V in HIV-1 Non-B Subtypes
Mohamed Said Sylla
Journal of Antivirals & Antiretrovirals, 2012
View PDFchevron_right
In Vitro Evolution of the Human Immunodeficiency Virus Type 1 Gag-Protease Region and Maintenance of Reverse Transcriptase Resistance following Prolonged Drug Exposure
Massimo Galli
Journal of Clinical Microbiology, 2001
View PDFchevron_right
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
Robert Shafer
AIDS, 2007
View PDFchevron_right
Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
Andrew Zolopa
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right